查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594515

食用动物非治疗性抗生素市场：依抗生素类别、给药途径、目标动物和抗生素活性成分分类－2025-2030年全球预测

Non-Therapeutic Antibiotics for Food Animals Market by Antibiotic Class, Route of Administration, Target Animal, Antibiotic Active Ingredient - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年食用动物非治疗性抗生素市值为47.9亿美元，预计2024年将达51.3亿美元，复合年增长率为7.18%，到2030年将达到77.9亿美元，预计将达到90美元百万。

食用动物非治疗性抗生素市场的范围和定义是出于治疗疾病以外的原因而使用抗生素，主要是为了促进家禽、牛、猪等牲畜的生长，并以提高饲料效率为目的。对此类抗生素的需求源于对高品质肉类、鸡蛋和酪农，而这需要高效的生产系统。这些抗生素用于预防性施用，以维持疾病传播风险增加的集中农业作业中的动物健康和生产力。然而，监管压力和消费者意识正在改变最终用途的范围，减少抗生素的使用并青睐益生菌和有机农业等替代品。

主要市场统计
基准年[2023] 47.9亿美元
预测年份 [2024] 51.3亿美元
预测年份 [2030] 77.9亿美元
复合年增长率（%） 7.18%

该市场的关键成长要素包括全球肉品消费量的增加、畜牧业的进步以及兽医健康的持续研究。新的商机在于开发益生元和植物源等抗生素替代品，以及加强农场的生物安全措施。然而，市场面临重大挑战，包括限制抗生素使用的严格法规、消费者对不含抗生素产品的偏好增加以及始终存在的抗菌素抗药性 (AMR) 威胁。这些因素需要采取平衡的方法，利用创新研究来提高效率，同时又不损害公共卫生或动物福利。

创新极为重要，例如基于奈米技术的药物输送系统、精准营养以及牲畜天然抵抗疾病的基因进步。这些行业预计不仅能够满足更严格的法规，而且在品质和永续性方面具有优势。公司应该投资于研发伙伴关係以及与学术机构的合作来开拓这些解决方案。因此，市场正在朝着永续成长的方向发展，需要依靠道德生产、高效和可追溯的供应链来有效满足消费者的期望和监管要求。对于希望在这个充满活力的市场环境中生存并蓬勃发展的企业来说，解决这些因素至关重要。

市场动态：快速发展的食用动物非治疗性抗生素市场的关键市场洞察

供需的动态交互作用正在改变食用动物的非治疗性抗生素市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球对动物性蛋白质的需求不断增加
    • 增加使用以提高产量和预防疾病
  • 市场限制因素
    • 关于非治疗性抗生素使用的严格政府法规
  • 市场机会
    • 政府措施
  • 市场挑战
    • 对植物来源肉类的需求不断增加

波特五力：开拓食用动物非治疗性抗生素市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对食用动物非治疗性抗生素市场的外部影响

外部宏观环境因素在影响食用动物非治疗性抗生素市场表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解食用动物非治疗性抗生素市场的竞争格局

对食用动物市场非治疗性抗生素的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

食品动物非治疗性抗生素市场供应商的 FPNV 定位矩阵绩效评估

FPNV定位矩阵是评估食用动物非治疗性抗生素市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，为食用动物非治疗性抗生素市场的成功指明道路

对于旨在加强其在全球市场的影响力的公司来说，对食用动物非治疗性抗生素市场进行策略性分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球对动物性蛋白质的需求增加
      • 增加使用以提高生产力和预防疾病
    • 抑制因素
      • 关于非治疗性抗生素使用的严格政府法规
    • 机会
      • 加强政府努力发展水产养殖业
    • 任务
      • 对植物来源肉品的需求增加
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 依抗生素类型分類的食用动物非治疗性抗生素市场

  • 医学上重要的
    • Aminoglycosides
    • 头孢菌素
    • 兰考酰胺
    • 大环内酯
    • 青霉素
    • 磺胺类药物
    • 四环霉素
  • 在医学上不重要
    • 离子载体

第七章食用动物用非治疗性抗生素市场：依给药途径

  • 配合饲料
  • 饲料混合物
  • 饲料预混合料
  • 水

第八章 食用动物非治疗性抗生素市场 目标动物

  • 水产饲料
  • 牛饲料
  • 家禽饲料
  • 猪饲料

第九章 食用动物非治疗性抗生素市场 抗生素有效成分

  • Ampicillin和阿莫西林
  • 桿菌胜肽
  • 庆大霉素
  • 四环霉素
  • 沙利霉素
  • 磺胺喹喔啉
  • 泰乐菌素

第10章：美洲食用动物非治疗性抗生素市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太食用动物非治疗性抗生素市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲食用动物非治疗性抗生素市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Alfasan Group of Companies
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Engormix
  • F. Hoffmann-La Roche Ltd.
  • Huvepharma
  • Kremoint Pharma Pvt. Ltd.
  • Lupin Limited
  • Merck KGaA
  • Novartis AG
  • Sanofi SA
  • Vega Group company limited
  • Vetoquinol SA
  • Virbac
Product Code: MRR-036C5CF3B529

The Non-Therapeutic Antibiotics for Food Animals Market was valued at USD 4.79 billion in 2023, expected to reach USD 5.13 billion in 2024, and is projected to grow at a CAGR of 7.18%, to USD 7.79 billion by 2030.

The scope and definition of the non-therapeutic antibiotics market for food animals encompass the use of antibiotics for reasons beyond treating diseases, primarily to promote growth and improve feed efficiency in livestock such as poultry, cattle, and swine. The necessity of such antibiotics arises from the increasing demand for high-quality meat, eggs, and dairy, which requires efficient production systems. These antibiotics are applied prophylactically to maintain animal health and productivity in intensive farming operations where disease transmission risk is heightened. However, the end-use scope is witnessing a shift due to regulatory pressures and consumer awareness, pushing for reduced antibiotic use and favoring alternatives like probiotics and organic farming practices.

KEY MARKET STATISTICS
Base Year [2023] USD 4.79 billion
Estimated Year [2024] USD 5.13 billion
Forecast Year [2030] USD 7.79 billion
CAGR (%) 7.18%

Key growth influencers in this market include the rising global meat consumption, advancements in animal husbandry practices, and ongoing research in veterinary health. Emerging opportunities lie in developing antibiotic alternatives, such as prebiotics and phytogenics, and enhancing biosecurity measures in farms. However, the market faces significant challenges, such as stringent regulations limiting antibiotic use, increasing consumer preference for antibiotic-free products, and the ever-present threat of antimicrobial resistance (AMR). These factors necessitate a balanced approach, leveraging innovative research to enhance efficiencies without compromising public health or animal welfare.

Innovation is critical, with prospects in nanotechnology-based drug delivery systems, precision nutrition, and genetic advancements in livestock to naturally resist diseases. These areas promise not only to align with stricter regulations but also provide an edge in quality and sustainability. Companies should invest in R&D partnerships and collaborations with academic institutions to pioneer these solutions. Consequently, the market is evolving towards sustainable growth, demanding a strategic focus on ethically produced, efficient, and traceable supply chains to meet consumer expectations and regulatory demands effectively. Addressing these factors is vital for businesses aiming to not only survive but also thrive in this dynamic market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Non-Therapeutic Antibiotics for Food Animals Market

The Non-Therapeutic Antibiotics for Food Animals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing demand for animal protein globally
    • Rising use for increasing production and prevention from diseases
  • Market Restraints
    • Stringent government regulations on use of non-therapeutic antibiotics
  • Market Opportunities
    • Increasing government initiatives for development of aquaculture
  • Market Challenges
    • Increasing demand for plant-based meat products

Porter's Five Forces: A Strategic Tool for Navigating the Non-Therapeutic Antibiotics for Food Animals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Non-Therapeutic Antibiotics for Food Animals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Non-Therapeutic Antibiotics for Food Animals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Non-Therapeutic Antibiotics for Food Animals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Non-Therapeutic Antibiotics for Food Animals Market

A detailed market share analysis in the Non-Therapeutic Antibiotics for Food Animals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Non-Therapeutic Antibiotics for Food Animals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Non-Therapeutic Antibiotics for Food Animals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Non-Therapeutic Antibiotics for Food Animals Market

A strategic analysis of the Non-Therapeutic Antibiotics for Food Animals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Non-Therapeutic Antibiotics for Food Animals Market, highlighting leading vendors and their innovative profiles. These include Alfasan Group of Companies, Boehringer Ingelheim GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Engormix, F. Hoffmann-La Roche Ltd., Huvepharma, Kremoint Pharma Pvt. Ltd., Lupin Limited, Merck KGaA, Novartis AG, Sanofi S.A., Vega Group company limited, Vetoquinol SA, and Virbac.

Market Segmentation & Coverage

This research report categorizes the Non-Therapeutic Antibiotics for Food Animals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Antibiotic Class, market is studied across Medically Important and Non-Medically Important. The Medically Important is further studied across Aminoglycosides, Cephalosporin, Lancosamides, Macrolide, Penicillin, Sulfas, and Tetracyclines. The Non-Medically Important is further studied across Ionophores.
  • Based on Route of Administration, market is studied across Compound Feed, Feed Mixtures, Feed Premix, and Water.
  • Based on Target Animal, market is studied across Aqua Feed, Cattle Feed, Poultry Feed, and Swine Feed.
  • Based on Antibiotic Active Ingredient, market is studied across Ampicillin & Amoxycillin, Bacitracin, Gentamicin, Oxytetracyclines, Salinomycin, Sulfaquinoxaline, and Tylosin.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing demand for animal protein globally
      • 5.1.1.2. Rising use for increasing production and prevention from diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent government regulations on use of non-therapeutic antibiotics
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing government initiatives for development of aquaculture
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing demand for plant-based meat products
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Non-Therapeutic Antibiotics for Food Animals Market, by Antibiotic Class

  • 6.1. Introduction
  • 6.2. Medically Important
    • 6.2.1. Aminoglycosides
    • 6.2.2. Cephalosporin
    • 6.2.3. Lancosamides
    • 6.2.4. Macrolide
    • 6.2.5. Penicillin
    • 6.2.6. Sulfas
    • 6.2.7. Tetracyclines
  • 6.3. Non-Medically Important
    • 6.3.1. Ionophores

7. Non-Therapeutic Antibiotics for Food Animals Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Compound Feed
  • 7.3. Feed Mixtures
  • 7.4. Feed Premix
  • 7.5. Water

8. Non-Therapeutic Antibiotics for Food Animals Market, by Target Animal

  • 8.1. Introduction
  • 8.2. Aqua Feed
  • 8.3. Cattle Feed
  • 8.4. Poultry Feed
  • 8.5. Swine Feed

9. Non-Therapeutic Antibiotics for Food Animals Market, by Antibiotic Active Ingredient

  • 9.1. Introduction
  • 9.2. Ampicillin & Amoxycillin
  • 9.3. Bacitracin
  • 9.4. Gentamicin
  • 9.5. Oxytetracyclines
  • 9.6. Salinomycin
  • 9.7. Sulfaquinoxaline
  • 9.8. Tylosin

10. Americas Non-Therapeutic Antibiotics for Food Animals Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Non-Therapeutic Antibiotics for Food Animals Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Non-Therapeutic Antibiotics for Food Animals Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alfasan Group of Companies
  • 2. Boehringer Ingelheim GmbH
  • 3. Ceva Sante Animale
  • 4. Dechra Pharmaceuticals PLC
  • 5. Engormix
  • 6. F. Hoffmann-La Roche Ltd.
  • 7. Huvepharma
  • 8. Kremoint Pharma Pvt. Ltd.
  • 9. Lupin Limited
  • 10. Merck KGaA
  • 11. Novartis AG
  • 12. Sanofi S.A.
  • 13. Vega Group company limited
  • 14. Vetoquinol SA
  • 15. Virbac

LIST OF FIGURES

  • FIGURE 1. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET RESEARCH PROCESS
  • FIGURE 2. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET DYNAMICS
  • TABLE 7. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CEPHALOSPORIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY LANCOSAMIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MACROLIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY IONOPHORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COMPOUND FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED MIXTURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY FEED PREMIX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY WATER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AQUA FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY CATTLE FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY POULTRY FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SWINE FEED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY AMPICILLIN & AMOXYCILLIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY BACITRACIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY GENTAMICIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY OXYTETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SALINOMYCIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY SULFAQUINOXALINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TYLOSIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 171. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 172. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 173. EGYPT NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 177. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 179. FINLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 183. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 185. FRANCE NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 189. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 191. GERMANY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 195. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 196. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 197. ISRAEL NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 201. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 203. ITALY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 208. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 213. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 215. NIGERIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 219. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 220. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 221. NORWAY NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 225. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 226. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 227. POLAND NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 231. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 233. QATAR NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 237. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 238. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 239. RUSSIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 244. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 250. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 255. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 256. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY TARGET ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 257. SPAIN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY ANTIBIOTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY MEDICALLY IMPORTANT, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN NON-THERAPEUTIC ANTIBIOTICS FOR FOOD ANIMALS MARKET SIZE, BY NON-MEDICALLY IMPORTANT, 20